Intelimedix – Trademark Portfolio

Entity Type: 16

Intelimedix has 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in Lakeland, FL.

6810 New Tampa Highway Suite 400

Lakeland, FL 33815

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Intelimedix's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (2 filings)

Legal services; security services for the protection of property and individuals

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Intelimedix have?

Intelimedix has 12 U.S. trademarks filed with the USPTO.

What trademark classes does Intelimedix file in?

Intelimedix files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What is Intelimedix's trademark registration success rate?

Intelimedix has a 0% trademark registration rate, with 0 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.